Corteva (CTVA)
(Delayed Data from NYSE)
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Zacks News
Corteva, Inc. (CTVA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Influence Keurig (KDP) in Q1 Earnings
by Zacks Equity Research
Keurig's (KDP) Q1 results are likely to reflect solid demand, and in-market performance across categories and brands. Inflationary costs and supply-chain woes are likely to have hurt.
Factors Likely to Influence Newell (NWL) in Q1 Earnings
by Zacks Equity Research
Higher costs, inflationary pressure and supply-chain woes are likely to have hurt Newell's (NWL) Q1 performance. Robust consumption, strong demand and core sales growth are likely to have aided.
Factors to Decide Archer Daniels' (ADM) Fate in Q1 Earnings
by Zacks Equity Research
Archer Daniels' (ADM) Q1 results are likely to reflect gains from solid demand, continued strength in the Nutrition segment and efforts to expand its solutions portfolio via buyouts and partnerships.
Factors Likely to Affect Procter & Gamble's (PG) Q3 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results are expected to reflect gains from strong consumer demand, and productivity and cost-saving initiatives. Higher input and freight costs are likely to have ailed.
Zacks Industry Outlook Highlights: Archer Daniels Midland Company, Corteva Inc., Adecoagro S.A., Calavo Grower and Alico Inc
by Zacks Equity Research
Archer Daniels Midland Company, Corteva Inc., Adecoagro S.A., Calavo Grower and Alico Inc. are highlighted in this Industry Outlook article.
5 Stocks to Watch in a Prospering Agriculture Operations Industry
by Rajani Lohia
The Agriculture - Operations industry looks well-placed for growth, driven by the solid demand for healthy and organic products amid challenging supply-chain conditions and high input costs. Players like ADM, CTVA, AGRO, CVGW and ALCO have placed themselves well.
Corteva, Inc. (CTVA) Q4 Earnings Match Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 0% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Corteva, Inc. (CTVA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -7.69% and 21.20%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Has Corteva, Inc. (CTVA) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and Coca-Cola (KO) have performed compared to their sector so far this year.
DOLE vs. CTVA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
DOLE vs. CTVA: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Corteva, Inc. (CTVA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 57.58% and 17.20%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods (BGS) Queued Up for Q3 Earnings: Key Aspects to Note
by Zacks Equity Research
B&G Foods' (BGS) third-quarter performance is likely to have been affected by higher input costs, such as raw materials and transportation.
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.
Corteva, Inc. (CTVA) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Corteva, Inc. (CTVA) Could Beat Earnings Estimates Again
by Zacks Equity Research
Corteva, Inc. (CTVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Factors Likely to Decide the Fate of AB InBev (BUD) in Q3
by Zacks Equity Research
Commodity cost inflation, adverse currency and higher SG&A expenses are expected to have hurt AB InBev (BUD) in Q3. Strong brand portfolio and digital growth are likely to have aided.
Colgate (CL) to Post Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Colgate's (CL) third-quarter performance is likely to reflect gains from favorable consumer demand supported by continued innovation and market-expansion efforts.
Here's How FEMSA (FMX) is Positioned Just Ahead of Q3 Earnings
by Zacks Equity Research
FEMSA (FMX) is likely to have gained from improved consumption trends, business momentum, digital initiatives and business expansion endeavors in Q3. Supply-chain disruptions are likely to have hurt.
Zacks Industry Outlook Highlights: Archer Daniels Midland Company, Corteva, Mission Produce, Adecoagro and Alico
by Zacks Equity Research
Zacks Industry Outlook Highlights: Archer Daniels Midland Company, Corteva, Mission Produce, Adecoagro and Alico
5 Agriculture Operations Stocks to Watch Amid Supply-Chain and Cost Woes
by Rajani Lohia
Challenging supply-chain conditions and high input costs are expected to mar the Agriculture - Operations industry. However, players like ADM, CTVA, AVO, AGRO and ALCO have placed themselves well with innovations and investments.
Corteva, Inc. (CTVA) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 12.00% and 6.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
K, BYND & 3 Other Food Stocks to Watch for Earnings on August 5
by Vrishali Bagree
While food stocks may show gains from foodservice recovery and solid demand, high costs are a woe for Kellogg (K), Beyond Meat (BYND), Post Holdings (POST), Celsius Holdings (CELH) and Corteva (CTVA).